Abstract
Nuclear medicine has an important role in benign and malignant bone diseases. Its role has been expanding significantly particularly in the diagnosis of many benign diseases which may not be detected by morphologic modalities. Table 7.1 summarizes the modalities used in the diagnosis of bone diseases and their main advantages.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Coleman RE (1997) Skeletal complications of malignancy. Cancer 80(suppl):1588–1594
Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165–176
Elgazzar A (2004) Orthopedic nuclear medicine. Springer, Berlin/New York
Evan-Sapir E (2005) Imaging of malignant bone involvement by morphologic, scintigraphic and hybrid modalities. J Nucl Med 46:1356–1367
Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN (2000) Cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Cancer Base No. 5. IARC, Lyon. Available at: http://www-dep.iarc.fr/globocan/cdrom.htm
Palestro CJ, Love C (2007) Radionuclide imaging of musculoskeletal infection: convertional agents. Semin Musculoskeletal Radiol 11:335–352
Schauwecker DS (1992) The scintigraphic diagnosis of osteomyelitis. Am J Roentgenol 158:9–18
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Elgazzar, A.H. (2011). Skeletal System. In: A Concise Guide to Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19426-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-19426-9_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-19425-2
Online ISBN: 978-3-642-19426-9
eBook Packages: MedicineMedicine (R0)